Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In AML

AML for July/August 2016

Predicting Risk of Post Auto-HCT Relapse in AML , Biol Blood Marrow Transplant; ePub 2016 Aug 18; Mule, et al

Treatment Patterns in Newly Diagnosed AML , Clin Lymphoma Myeloma Leuk; ePub 2016 Aug 10; Ma, et al

Therapy-Related AML Outcomes Evaluated , Clin Lymphoma Myeloma Leuk; ePub 2016 Aug 10; Sasaki, et al

Consider This to Assess Relapse Risk Before AlloHSCT, Biol Blood Marrow Transplant; ePub 2016 Jul 29; Luskin, et al

Autologous HCT in Intermediate-Risk AML Patients , Leuk Lymphoma; 2016 Jul; Mannis, Martin, et al

More must reads

AML for May/June 2016

Genomic Classification and Prognosis in AML, N Engl J Med; 2016 Jun 9; Papaemmanuil, et al

Impact of Respiratory Status on Hyperleukocytic AML, Leuk Lymphoma; 2016 Jun; Van de Louw, et al

More must reads

AML for January/February 2016

CMV Reactivation in Hematologic Disease, Does it confer protection?

Donor Leukocyte Infusion in Relapsed Leukemia and MDS, Comparing unrelated DLI with matched sibling DLI

Minimal Residual Disease in AML, Assessing its prognostic value

Hypomethylating Agents in Secondary AML, Evaluating prognoses after progression from myeolodysplastic syndromes

More must reads

AML for November/December 2015

Minimal Residual Disease in Acute Myeloid Leukemia, Should it be the basis for disease assessment?

Obesity in Acute Myelogenous Leukemia, Comparing survival rates in patients with APL and non-APL AML

Conditioning Following AlloHCT, Comparing myeloablative to reduced-intensity conditioning

Variant Allele Frequency in MDS, Do gene mutations have prognostic value?

Stem-Cell Transplantation in Older Patients, Studying survival in patients aged > 60 years

More must reads

AML for September/October 2015

Risk of AML and MDS After First Cancers, Are type of cancer and radiation status informative?

MDS and AML in Breast Cancer, Studying associations with therapies

Lifestyle and Environmental Exposures in AML, Studying associations with risk

Umbilical Cord Blood Transfusions in AML, Are they effective in older patients?

Social Factors in AML , Do they increase mortality risk?

More must reads

Pages